Government Tender Published for Dapagliflozin 5 mg plus Metformin 1000 mg IR Tab,Diosmin 900 Mg and Hesperidin 100 Mg Tab,Tab Dutas

The eligibility requirements include being a registered entity in India with the necessary licenses and certifications. Additionally, suppliers should have prior experience in delivering similar pharmaceutical products to be considered qualified for this procurement.

Bidders must provide relevant licenses related to pharmaceutical manufacturing, distribution, and compliance with quality control standards. These certifications are crucial to ensure the reliability and safety of the medicines supplied.

Vendors can register on the GeM portal by providing the necessary documentation, including business registration, GST registration, and relevant licenses. Following successful registration, they can participate in ongoing and upcoming tenders.

All submissions should be made electronically in PDF or other specified formats on the GeM portal. It is important for bidders to adhere to the format guidelines specified in the tender documents.

Yes, bidders must comply with the detailed technical specifications outlined in the tender documents. This includes the formulation, dosage, and packaging requirements of the medicines listed in the procurement.

All supplied medicines must comply with industry-standard quality benchmarks including GMP (Good Manufacturing Practices) and regulations set forth by health authorities. This ensures that the medicines are safe and effective.

Compliance requirements include adherence to all relevant laws governing pharmaceutical manufacturing and distribution, ensuring that all products are certified for safety and efficacy before delivery.

The Earnest Money Deposit (EMD) for this tender is set at 135,000. This deposit is intended to secure the bid and ensure that only serious contenders participate. The EMD will be returned to unsuccessful bidders after the conclusion of the tender process.

The performance security, if required, must be provided by the successful bidder post-award of the contract. This ensures compliance with the delivery schedule and the specifications set by the tender.

Payment terms will be disclosed in the tender document, but typically involve payment upon delivery or after the successful completion of the project phase, contingent upon the adherence to the contract stipulations.

Price evaluations will consider the total value alongside compliance with the delivery requirements. Cost-effectiveness is vital, but it should not compromise quality standards.

Documents must be submitted electronically via the GeM portal. This includes uploading all required documents directly to the tender submission interface.

While precise dates are not disclosed, bidders must adhere to the timelines stated in the tender documents regarding submission and evaluations.

The evaluation process will be rigorous, where bids will be assessed based on both technical proficiency and financial offer. The aim is to select suppliers who can deliver quality while ensuring value for money.

Notification of results will typically be posted on the GeM portal after the evaluation process concludes. Bidders should regularly check this platform for updates.

MSEs may receive advantages during the evaluation process, such as price preference or relaxation of certain requirements, aimed at promoting greater participation and competition in government procurements.

Startups are encouraged to participate under the provisions aimed at fostering innovation. Specific criteria may be relaxed for such entities to promote competitive offerings in the bid.

Suppliers must demonstrate the domestic production of the pharmaceutical products being offered, aligning their proposals with the 'Make in India' initiative aimed at boosting local manufacturing.

Bidders should follow local content requirements as specified by government procurement rules, ensuring that a certain percentage of the products constitute local goods, thereby supporting domestic industries.